Dec 19, 2020 05:53 PM (GMT+8) · EqualOcean
Today, Jinlian holding and Shangshi group held a signing ceremony for the mixed reform of Tianjin Pharmaceutical Group in Wanli Tianjin Hotel, marking the significant achievements of Tianjin Pharmaceutical Group in the mixed reform. It is reported that the mixed reform project of Tianjin Pharmaceutical Group was publicly listed in Tianjin property rights trading center on September 29, 2020, and Tianjin Hushen Biomedical Technology Co., Ltd. obtained 67% equity of Pharmaceutical Group. In order to participate in the mixed reform of Pharmaceutical Group, Shanghai Shangshi group led the establishment of Tianjin Hushen Biomedical Technology Co., Ltd., with a registered capital of 5 billion yuan.